{{Rsnum
|rsid=1801406
|Gene=BRCA2
|Chromosome=13
|position=32337751
|Orientation=plus
|GMAF=0.2787
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BRCA2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 54.9 | 39.8 | 5.3
| HCB | 40.1 | 54.0 | 5.8
| JPT | 23.9 | 56.6 | 19.5
| YRI | 62.6 | 33.3 | 4.1
| ASW | 64.9 | 31.6 | 3.5
| CHB | 40.1 | 54.0 | 5.8
| CHD | 45.9 | 41.3 | 12.8
| GIH | 49.5 | 46.5 | 4.0
| LWK | 73.6 | 24.5 | 1.8
| MEX | 58.6 | 37.9 | 3.4
| MKK | 80.1 | 18.6 | 1.3
| TSI | 55.9 | 34.3 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=19902366
|Title=Genetic variation in DNA repair genes and [[prostate cancer]] risk: results from a population-based study
|OA=1
}}

{{PMID Auto
|PMID=21346221
|Title=Risk of acute promyelocytic [[leukemia]] in [[multiple sclerosis]]: coding variants of DNA repair genes
}}

{{ClinVar
|rsid=1801406
|Reversed=0
|FwdREF=A
|FwdALT=C,G
|REF=A
|ALT=C,G
|RSPOS=32911888
|CHROM=13
|GMAF=0.2788
|dbSNPBuildID=89
|SSR=0
|SAO=0
|VP=0x050168000b0117051f100101
|GENEINFO=BRCA2:675
|GENE_NAME=BRCA2
|GENE_ID=675
|WGT=1
|VC=SNV
|CLNALLE=1; 2
|CLNHGVS=NC_000013.10:g.32911888A>C; NC_000013.10:g.32911888A>G
|CLNSIG=1
|Tags=PM;PMC;SLO;NSM;REF;SYN;VLD;G5A;G5;HD;GNO;KGPhase1;KGPilot123;KGPROD;OTHERKG;PH3;LSD
|CAF=0.7213; 0.2787
|COMMON=1
}}

{{PMID Auto
|PMID=16857995
|Title=Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.
|OA=1
}}

{{PMID Auto
|PMID=19276285
|Title=Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer.
|OA=1
}}

{{PMID Auto
|PMID=19644020
|Title=Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | Illumina Human 1M}}